Article PDF
Avoid common mistakes on your manuscript.
References
A Neugut M Hayek G Howe (1996) ArticleTitleEpidemiology of gastric cancer Semin Oncol 23 281–91 Occurrence Handle1:STN:280:BymB2c3pvFE%3D Occurrence Handle8658212
P Pisani DM Parkin F Bray J Ferlay (1999) ArticleTitleEstimates of the worldwide mortality from 25 cancers in 1990 Int J Cancer 83 18–29 Occurrence Handle1:STN:280:DyaK1MzotVaiuw%3D%3D Occurrence Handle10449602
JA Wils HO Klein JT Wagener H Bleiberg A Reis F Korsten et al. (1991) ArticleTitleSequential high-dose methotrexate and fluorouracil combined with doxorubicin—a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group J Clin Oncol 9 827–31 Occurrence Handle1:STN:280:By6B3c3itV0%3D Occurrence Handle2016625
U Vanhoefer P Rougier H Wilke MP Ducreux AJ Lacave E Van Cutsem et al. (2000) ArticleTitleFinal results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group J Clin Oncol 14 2648–57
W Koizumi S Tanabe K Saigenji A Ohtsu N Boku F Nagashima et al. (2003) ArticleTitlePhase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer Br J Cancer 89 2207–12 Occurrence Handle10.1038/sj.bjc.6601413 Occurrence Handle1:CAS:528:DC%2BD3sXpvVShtbc%3D Occurrence Handle14676796
A Ohtsu (2005) ArticleTitleCurrent status and future prospects of chemotherapy for metastatic gastric cancer: a review Gastric Cancer 8 95–102 Occurrence Handle10.1007/s10120-005-0324-9 Occurrence Handle1:CAS:528:DC%2BD2MXjvVCntbk%3D Occurrence Handle15864716
YH Kim SW Shin BS Kim JH Kim JG Kim YJ Mok et al. (1999) ArticleTitlePaclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma Cancer 85 295–301 Occurrence Handle1:CAS:528:DyaK1MXhtFGgt7w%3D Occurrence Handle10023695
AD Roth R Maibach G Martinelli N Fazio MS Aapro O Pagani et al. (2000) ArticleTitleDocetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO) Ann Oncol 11 301–6 Occurrence Handle10.1023/A:1008342013224 Occurrence Handle1:STN:280:DC%2BD3c3mvFKgsQ%3D%3D Occurrence Handle10811496
AD Roth J Ajani (2003) ArticleTitleDocetaxel-based chemotherapy in the treatment of gastric cancer Ann Oncol 14 41–4
U Vanhoefer H Wilke A Harstrick (1999) ArticleTitlePhase II study of docetaxel as second line chemotherapy (CT) in metastatic gastric cancer Proc Am Soc Clin Oncol 18 1163
SY Lin PH Chen CK Wang JD Liu CP Siauw YJ Chen et al. (1993) ArticleTitleMutation analysis of k-ras oncogenes in gastroenterologic cancers by the amplified created restriction sites method Am J Clin Pathol 100 686–9 Occurrence Handle1:CAS:528:DyaK2MXjsVeqsQ%3D%3D Occurrence Handle8249918
A Horii S Nakatsuru Y Miyoshi S Ichii H Nagase Y Kato et al. (1992) ArticleTitleThe APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer Cancer Res 52 3231–3 Occurrence Handle1:CAS:528:DyaK38Xkt1Cjsbs%3D Occurrence Handle1317264
PA Jones PW Laird (1999) ArticleTitleCancer epigenetics comes of age Nat Genet 21 163–7 Occurrence Handle10.1038/5947 Occurrence Handle1:CAS:528:DyaK1MXpsVClug%3D%3D Occurrence Handle9988266
SB Baylin M Esteller MR Rountree KE Bachman K Schuebel JG Harman (2001) ArticleTitleAberrant patterns of DNA methylation, chromatin formation and gene expression in cancer Hum Mol Genet 10 687–92 Occurrence Handle10.1093/hmg/10.7.687 Occurrence Handle1:CAS:528:DC%2BD3MXjt1ajsLY%3D Occurrence Handle11257100
H Suzuki F Itoh M Toyota T Kikuchi H Kakiuchi Y Hinoda et al. (1999) ArticleTitleDistinct methylation pattern and microsatellite instability in sporadic gastric cancer Int J Cancer 83 309–13 Occurrence Handle10.1002/(SICI)1097-0215(19991029)83:3<309::AID-IJC4>3.0.CO;2-Z Occurrence Handle1:CAS:528:DyaK1MXntVeltrw%3D Occurrence Handle10495421
M Toyota N Ahuja H Suzuki F Itoh M Ohe-Toyota K Imai et al. (1999) ArticleTitleAberrant methylation in gastric cancer associated with the CpG island methylator phenotype Cancer Res 59 5438–42 Occurrence Handle1:CAS:528:DyaK1MXnt1Gjurw%3D Occurrence Handle10554013
T Kikuchi M Toyota F Itoh H Suzuki T Obata H Yamamoto et al. (2002) ArticleTitleInactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors Oncogene 21 2741–9 Occurrence Handle10.1038/sj.onc.1205376 Occurrence Handle1:CAS:528:DC%2BD38XjsVSmsrk%3D Occurrence Handle11965547
JP Issa M Toyota (2005) ArticleTitleCIMP, at last Gastroenterology 129 1121–4 Occurrence Handle10.1053/j.gastro.2005.07.040 Occurrence Handle1:CAS:528:DC%2BD2MXhtV2isrfI Occurrence Handle16143149
M Toyota JP Issa (1999) ArticleTitleCpG island methylator phenotypes in aging and cancer Semin Cancer Biol 9 349–57 Occurrence Handle10.1006/scbi.1999.0135 Occurrence Handle1:CAS:528:DyaK1MXntVagsr0%3D Occurrence Handle10547343
DM Scolnick TD Halazonetis (2000) ArticleTitleChfr defines a mitotic stress check point that delays entry into metaphase Nature 406 430–5 Occurrence Handle1:CAS:528:DC%2BD3cXlslKnu7c%3D Occurrence Handle10935642
D Cortez SJ Elledge (2000) ArticleTitleConducting the mitotic symphony Nature 406 354–6 Occurrence Handle1:CAS:528:DC%2BD3cXlslKjur8%3D Occurrence Handle10935617
Y Shibata N Haruki Y Kuwabara H Ishiguro N Shinoda A Sato et al. (2002) ArticleTitleChfr expression is downregulated by CpG island hypermethylation in esophageal cancer Carcinogenesis 23 1695–700 Occurrence Handle1:CAS:528:DC%2BD38XnvF2qsbo%3D Occurrence Handle12376479
K Mizuno H Osada Y Tatematsu T Mitsudomi T Fujii T Takahashi (2002) ArticleTitleAberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers Oncogene 21 2328–33 Occurrence Handle10.1038/sj.onc.1205402 Occurrence Handle1:CAS:528:DC%2BD38XivFykuro%3D Occurrence Handle11948416
A Sato M Toyota F Itoh Y Sasaki H Suzuki K Ogi et al. (2003) ArticleTitleEpigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer Cancer Res 63 8606–13
Y Koga Y Kitajima A Miyoshi K Sato S Sato K Miyazaki (2006) ArticleTitleThe significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer J Gastroenterol 41 133–9
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Watanabe, Y., Itoh, F. Epigenetics modulates the effect of chemotherapy on gastric cancer. J Gastroenterol 41, 180–181 (2006). https://doi.org/10.1007/s00535-006-1776-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00535-006-1776-3